Lyra Therapeutics (LYRA) Q4 2024 Earnings

Nov 12Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.74
-0.55
-0.37
-0.18

Details

Expected EPS
-0.215
Actual EPS
-0.18
Surprise EPS
0.04
Surprise Percent
+16.28%

Description

⁨Lyra Therapeutics⁩ (⁦LYRA⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts